SCHEMBL16638374

SCHEMBL16638374

O=C(O)c1cnn(-c2nc(NC3CCCOC3)c3cc(Oc4ccc(Cl)cc4)ccc3n2)c1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623011 0.90 EGLN1 (1.00) EGLN1
SCHEMBL623141 0.89 EGLN1 (1.00) EGLN1
SCHEMBL621419 0.84 EGLN1 (1.00) EGLN1
SCHEMBL622459 0.82 EGLN1 (1.00) EGLN1
SCHEMBL14992463 0.80 EGLN1 (1.00) EGLN1
SCHEMBL621998 0.78 EGLN1 (1.00) EGLN1
SCHEMBL623414 0.78 EGLN1 (1.00) EGLN1
SCHEMBL623649 0.78 EGLN1 (1.00) EGLN1
SCHEMBL622190 0.77 EGLN1 (1.00) EGLN1
SCHEMBL621094 0.77 EGLN1 (1.00) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006251-B2 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors JANSSEN PHARAMCEUTICA NV (BE) 2015-04-14 US disclosed